NIH sponsored hypertension trial incites controversy: COI Thu, 21 Nov 2002 Controversy has erupted around the research disclosure process of a government sponsored, clinical trial that gave drug companies the manuscript of the report 30 days prior to its submission for publication in the Journal of the American Medical Association….
Artificial Heart experiment without informed consent? Wed, 30 Apr 2003 The manufacturer of an artificial heart, Abiomed, are seeking to use incapacitated patients who suffered a massive heart attack as human subjects without their informed consent. Does anyone have the moral or legal right to subject a human being to…
Op Ed: Psychiatry on the Ropes–WP / Evidence-based Psychiatry– Multi-Discipline Conference_ NYC Mon, 4 Oct 2004 An Op Ed article in The Washington Post by Shannon Brownlee (below) nails the elite procurers of psychotropic drugs who have long denied the ominous signals of drug-induced harm: “You’d think the psychiatric research…
Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article in The Washington Post addresses the key issue undermining public health and safety. Drug companies conceal unfavorable clinical trial findings: the tests failed to demonstrate that antidepressants are either safe or beneficial for…
Antidepressant drug induced Suicides: Evidence of “Iceberg effect” Revealed Thu, 10 Jun 2004 Canada West reports today: “At least five teenagers in Canada have died, four of suicide, while being treated with the most widely prescribed antidepressants in Canada and at least 100 other children as young as 18 months…
NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market Wed, 2 Jun 2004 The New York Times saw fit to print a report about preliminary, unpublished findings of a study whose authors claim to have “found that Prozac helps teenagers overcome depression far…
Daniel Troy Legacy: Public Virtually Defenseless against Unsafe Drugs Thu, 18 Nov 2004 The Associated Press reports that at a Congressional hearing today, Dr. David Graham a drug safety expert at the FDA told the Senate Finance Committee that the public is “virtually defenseless” if another medication such as Vioxx…
NIH: Public Servant or Private Marketer? Wed, 22 Dec 2004 David Willman of the Los Angeles Times provides an important reminder that the FDA is not the only government healthcare agency to have betrayed the public trust and lost its credibility. While the FDA has lent its seal of approval…
Leading ADHD Researcher Blows Whistle on Concerta & CHADD Fri, 3 Dec 2004 A newly released report by the Center for Disease Control – Health US 2004–reveals how effective the pharmaceutical industry is in marketing its drugs – whether or not they are beneficial; whether or not they cause severe…
FDA Approves Lilly’s Cymbalta for Depression Despite Risk of Suicide Wed, 4 Aug 2004 In a display of arrogance and defiance–in the midst of federal investigations into the marketing of antidepressants–the FDA has approved Eli Lilly’s antidepression drug, Cymbalta (duloxetine). Lilly’s press release announced: “Cymbalta, a balanced and potent reuptake…
Data from Unpublished Trials Suggest that Most SSRI Antidepressant Drugs Unsuitable for Children Wed, 21 Apr 2004 An independent analysis in next week’s The Lancet compares the published and unpublished data of pediatric SSRI antidepressant clinical trial data, finding the published reports not to be evidence-based. “In a global medical…
Government sanctioned Assault on Children and Pregnant Women Fri, 23 Jul 2004 President Bush’s New Freedom Commission on Mental Health has set off aggressive “screening for mental illness” initiatives that are nothing short of an assault on personal dignity and legal rights. The target population of forced mental health “screening,”…
